Evidence map›Paper›PMID 39842857›Full record

ArticleBMJ open respiratory research2025

Retrospective cross-sectional study on bronchiectasis in adult Aboriginal Australians: disease characteristics and comparison with ethnically diverse global bronchiectasis registry cohorts.

Subash Heraganahally, Claire Gibbs, Shiidheshwar J Ravichandran, Davaadorj Erdenebayar, Winnie Chen, Asanga Abeyaratne, Hubertus Jersmann, Lata Jayaram, Timothy Howarth

Abstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ open respiratory research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Prevalence of bronchiectasis: a narrative review.Therapeutic advances in respiratory disease
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Subash HeraganahallyDepartment of Respiratory and Sleep Medicine, Royal Darwin Hospital, Darwin, Northern Territory, Australia subash.heraganahally@nt.gov.au.ORCID http://orcid.org/0000-0003-0788-7137
Claire GibbsDepartment of Respiratory and Sleep Medicine, Royal Darwin Hospital, Darwin, Northern Territory, Australia.
Shiidheshwar J RavichandranDivision of General Medicine, Royal Darwin Hospital, Darwin, Northern Territory, Australia.
Davaadorj ErdenebayarDivision of General Medicine, Royal Darwin Hospital, Darwin, Northern Territory, Australia.
Winnie ChenNorthern Territory Medical Program, Flinders University College of Medicine and Public Health, Darwin, Northern Territory, Australia.
Asanga AbeyaratneDivision of General Medicine, Royal Darwin Hospital, Darwin, Northern Territory, Australia.
Hubertus JersmannDepartment of Respiratory and Sleep, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
Lata JayaramDepartment of Medicine, University of Melbourne, Melbourne, Victoria, Australia.
Timothy HowarthDarwin Respiratory and Sleep Health, Darwin Private Hospital, Darwin, Northern Territory, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGlobally, adult Indigenous people, including Aboriginal Australians, have a high burden of chronic respiratory disorders, and bronchiectasis is no exception. However, literature detailing bronchiectasis disease characteristics among adult Indigenous people is sparse. This study assessed the clinical profile of bronchiectasis among adult Aboriginal Australians and compared against previously published international bronchiectasis registry reports.

methodsAboriginal Australians aged >18 years with chest CT confirmed bronchiectasis between 2011 and 2020 in the Top End Northern Territory of Australia were included. Demographics, chest CT findings, pulmonary function results, sputum microbiology, coexistent medical comorbidities, and pharmacotherapy use were assessed and compared against five published international bronchiectasis registry reports (Australian (ABR), European (European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC)-Europe), Indian (EMBARC-India), Korean (KMBARC) and the USA (USBRR)).

resultsA total of 459 patients were assessed. In comparison with international and non-Aboriginal Australian national cohorts, Aboriginal Australians were younger (median 56 years (IQR (48, 65)); however, sex distribution (55% female) and body mass index (23 kg/m

conclusionThe overall bronchiectasis disease burden is higher in Aboriginal Australian adults in comparison with global ethnically diverse non-Indigenous populations. Further efforts are required to address this disparity secondary to bronchiectasis among Indigenous people.

Indexed as

Australian Aboriginal and Torres Strait Islander PeoplesBronchiectasisRegistriesAdultAgedAustraliaComorbidityCross-Sectional StudiesFemaleHumansMaleMiddle AgedRetrospective StudiesTomography, X-Ray ComputedAtypical Mycobacterial InfectionBronchiectasisClinical EpidemiologyCOPD epidemiologyEmphysemaImaging/CT MRI etcInhaler devicesRespiratory Function Test

Identifiers

PMID39842857
PMCPMC11784196

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.